Incidence and Impact of COVID-19 in MS
María Sepúlveda(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Albert Saiz(Hospital Clínic de Barcelona), Francesc Graus(Boston University), Eloy Martínez‐Heras(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Montse Artola(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Elisabeth Solana(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Domingo Escudero(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Martí Català(Nuffield Orthopaedic Centre), Clara Prats(Universitat Politècnica de Catalunya), Marta Aldea(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Mar Guasp(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Irene Pulido-Valdeolivas(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Carmen Montejo(Universitat de Barcelona), Laura Llansó(Universitat Autònoma de Barcelona), Yolanda Blanco(Fundació Clínic per a la Recerca Biomèdica), Eugenia Martínez‐Hernández(Universitat Autònoma de Barcelona), Ana Hernando(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Sara Llufriú(Hospital Clínic de Barcelona)
Cited by 37
Related Papers
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
|The Lancet Neurology|2013|3.1k
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
|The Lancet Neurology|2010|2.4k
Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series
|The Lancet Neurology|2010|1.4k
Antibody-Mediated Encephalitis
|New England Journal of Medicine|2018|1.3k